Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson's disease: A retrospective observational study using administrative claims data. (June 2020)
- Record Type:
- Journal Article
- Title:
- Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson's disease: A retrospective observational study using administrative claims data. (June 2020)
- Main Title:
- Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson's disease: A retrospective observational study using administrative claims data
- Authors:
- Iketani, Ryo
Imai, Shinobu
Horiguchi, Hiromasa
Furushima, Daisuke
Fushimi, Kiyohide
Yamada, Hiroshi - Abstract:
- Highlights: The present study detected 10 factors associated with AAP treatment. We developed two manners of stratification for PD patients using detected factors. Both stratification manners reflected physical morbidity of PD patients. Abstract: Evidence shows that atypical antipsychotics (AAPs), a treatment of psychosis in Parkinson's disease (PD), are associated with factors reflecting the severity of the disease. Therefore, we evaluated the applicability of these factors in risk stratification for physical morbidity in PD patients requiring AAPs. We implemented a nested case-control analysis using administrative claims data derived from PD inpatients in 143 National Hospitals in Japan between April 2012 and March 2017. The analysis compared PD patients exposed to AAPs with unexposed matched controls using conditional logistic regression. The cases were then stratified by the weighted score using the partial regression coefficients of extracted factors or the number of factors that they had. Physical morbidity was evaluated using length of stay (LOS) and readmission. After comparing the cases (n = 829) with the matched controls (n = 3316), 10 factors were extracted. The cases were stratified into four level groups using the weighted score, or five level groups using the number of factors. LOS was prolonged with increasing score (49.7; 58.5; 72.7; and 83.3 days) and number of factors (52.1; 52.9; 63.9; 80.7; and 79.1 days). Readmission within 30 days increased along withHighlights: The present study detected 10 factors associated with AAP treatment. We developed two manners of stratification for PD patients using detected factors. Both stratification manners reflected physical morbidity of PD patients. Abstract: Evidence shows that atypical antipsychotics (AAPs), a treatment of psychosis in Parkinson's disease (PD), are associated with factors reflecting the severity of the disease. Therefore, we evaluated the applicability of these factors in risk stratification for physical morbidity in PD patients requiring AAPs. We implemented a nested case-control analysis using administrative claims data derived from PD inpatients in 143 National Hospitals in Japan between April 2012 and March 2017. The analysis compared PD patients exposed to AAPs with unexposed matched controls using conditional logistic regression. The cases were then stratified by the weighted score using the partial regression coefficients of extracted factors or the number of factors that they had. Physical morbidity was evaluated using length of stay (LOS) and readmission. After comparing the cases (n = 829) with the matched controls (n = 3316), 10 factors were extracted. The cases were stratified into four level groups using the weighted score, or five level groups using the number of factors. LOS was prolonged with increasing score (49.7; 58.5; 72.7; and 83.3 days) and number of factors (52.1; 52.9; 63.9; 80.7; and 79.1 days). Readmission within 30 days increased along with increasing score (5.7; 10.2; 10.2 and 12.9%) and number of factors (5.9; 9.3; 8.9; 11.3; and 14.3%). We confirmed two stratification manners for physical morbidity in PD patients requiring AAPs. These manners would be useful for considering management plan for these patients. … (more)
- Is Part Of:
- Journal of clinical neuroscience. Volume 76(2020)
- Journal:
- Journal of clinical neuroscience
- Issue:
- Volume 76(2020)
- Issue Display:
- Volume 76, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 76
- Issue:
- 2020
- Issue Sort Value:
- 2020-0076-2020-0000
- Page Start:
- 189
- Page End:
- 194
- Publication Date:
- 2020-06
- Subjects:
- Administrative claims data -- Atypical antipsychotics -- Parkinson's disease -- Physical morbidity -- Psychosis -- Risk stratification
Brain -- Surgery -- Periodicals
Neurosciences -- Periodicals
Nervous system -- Surgery -- Periodicals
Brain -- surgery -- Periodicals
Neurosurgical Procedures -- Periodicals
Neurosciences -- Periodicals
Electronic journals
616.8 - Journal URLs:
- http://www.harcourt-international.com/journals ↗
http://www.sciencedirect.com/science/journal/09675868 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09675868 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jocn.2020.04.009 ↗
- Languages:
- English
- ISSNs:
- 0967-5868
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.585000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25107.xml